Close

Generic EpiPen to Hit Mylan (MYL) EPS by a Modest 2% - Leerink

Go back to Generic EpiPen to Hit Mylan (MYL) EPS by a Modest 2% - Leerink

Mylan to Launch First Generic to EpiPenĀ® Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product

August 29, 2016 6:00 AM EDT

HERTFORDSHIRE, England and PITTSBURGH, Aug. 29, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its U.S. subsidiary will launch the first generic to EpiPen® Auto-Injector (epinephrine injection, USP) at a list price of $300 per generic EpiPen® two-pack carton, which represents a discount of more than 50% to the Mylan list price, or wholesale acquisition cost ("WAC"), of the branded medicine. The authorized generic will be identical to the branded product, including device functionality and drug formulation. Mylan expects to launch the product in several weeks, pending completion of... More